Enrolling by invitationNCT05962398

Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)

Studying Hemophilia

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: CSL Behring
Principal Investigator: Study Director
CSL Behring
Intervention: AAV5-hFIXco-Padua(genetic)
Enrollment: 56 enrolled
Eligibility: 18 years · MALE
Timeline: 2023 – 2035

Study locations (28)

10-15 Phoenix Childrens Hospital, Phoenix, Arizona, United States
10-14 Arkansas Children's Hospital - Pharmacology, Little Rock, Arkansas, United States
10-22 Orthopaedic Institute for Children, Los Angeles, California, United States
10-21 Children's Hospital of Los Angeles, Los Angeles, California, United States
10-63 UC Davis Medical Center, Sacramento, California, United States
10-12 University of California, San Diego (UCSD), San Diego, California, United States
10-25 University of Colorado Denver, Aurora, Colorado, United States
10-19 University of South Florida, Tampa, Florida, United States
10-10 University of Michigan Medical Center, Ann Arbor, Michigan, United States
10-16 University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
10-18 Oregon Health & Science University, Portland, Oregon, United States
10-20 Vanderbilt University Medical Center, Nashville, Tennessee, United States
10-28 University of Texas Health Science Center, Houston, Texas, United States
10-26 University of Utah, Salt Lake City, Utah, United States
10-62 Washington Institute for Coagulation, Seattle, Washington, United States
+13 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05962398 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia →

← Back to all trials